Clinical Effect of Glutathione (Tathion) on Melasma.
- Author:
Ji Yoon HAN
;
Sun Ok PARK
;
Jeong Hee HAHM
;
Hong Il KOOK
- Publication Type:Original Article
- MeSH:
Copper;
Dihydroxyphenylalanine;
Glutathione*;
Humans;
Korea;
Melanins;
Melanosis*;
Tyrosine
- From:Korean Journal of Dermatology
1977;15(1):57-61
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Tatbion is a tripeptide, reduced form of Glutathione(GSH or p-glutamyl-cysteiny1 -glycine). Glutathione(SH compound)is believed to inhibit melanin formation by combining witb the copper in tyrnsinase whicb is essential in the conversion of tyrosine to DOPA (3, 4-dihydroxyphenylalanine) and DOPA to DOPA-quinone or by forming cornplex with the intermediate in the tyrosine-to-melaa.in reaction. The effect of Tathion in the treatment of melasma has not been reported in Korea. We have observed the effect of Tatbion in 150 patients with melasma. After the average duration of Gwks of treatment(50-100mg tree tirnes/daily), we were abIe to grade the results as follow. Excellent(Pigmentation almost disappeared): 17. 4 % Good (Pigmentation markedly improved): 56. 7% Fair (Pigmentation slightly improved: 7. 3% None (No effect) : 18.6% The result showed relatively good effects of Tathion in the treatment of 122pts (81.4%) with melasma in total. The brief review of literature on the treatment of melasma was undertaken.
